What Happened?
Cambridge, MA-based Kyn-Therapeutics Appointed Mark Manfredi as President and Chief Executive Officer
About the Company
Kyn Therapeutics is building a new generation of immuno-oncology therapies targeting powerful immunosuppressive metabolic networks. We envision a future where immunotherapies are the foundation of every cancer patient`s treatment, delivering rapid and durable responses. The Kyn team is composed of drug hunters, translational researchers and entrepreneurs drawn from many of the largest innovators in biotechnology supported by world-class advisors, and is backed by a seasoned board of directors anchored by OrbiMed Healthcare Fund Management and Atlas Venture. Kyn Therapeutics is headquartered in the biotech hub of Cambridge, Massachusetts.
About the Person
Mark Manfredi is President and Chief Executive Officer at Kyn Therapeutics. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile